IMCR vs RJF · rev $222.6M vs rev $15.91B
Immunocore Holdings Ltd (IMCR) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
RJF (RJF) common stock.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
IMCR currently screens at market cap $1.45B. RJF currently screens at market cap $0.
Not investment advice. Open the IMCR and RJF stock pages for the full models.
Not investment advice.